In Vitro and In Vivo Diagnostic Substances - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the In industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

In Vitro and In Vivo Diagnostic Substances - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - In Vitro and In Vivo Diagnostic Substances
Corporate Insider Buy Sell Ratio (Insider Count) - In Vitro and In Vivo Diagnostic Substances
In Vitro and In Vivo Diagnostic Substances - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-04-27 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP Footnote P - Purchase I 0
2026-04-27 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP P - Purchase D 3.6391 250,923
2026-04-24 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP P - Purchase D 3.5258 38,880
2026-04-24 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP Footnote P - Purchase I 0
2026-04-23 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP P - Purchase D 3.5025 280,381
2026-04-23 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP Footnote P - Purchase I 0
2026-04-20 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP P - Purchase D 3.8822 40,690
2026-04-20 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP Footnote P - Purchase I 0
2026-04-17 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP Footnote P - Purchase I 0
2026-04-17 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP P - Purchase D 3.5711 40,114
2026-04-17 LNTH / Lantheus Holdings, Inc. 4 Niedzwiecki Daniel F - Taxes D 83.82 -1,911
2026-04-16 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP P - Purchase D 3.4457 102,057
2026-04-16 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP Footnote P - Purchase I 0
2026-04-14 MYGN / Myriad Genetics, Inc. 4 Verratti Mark F - Taxes D 4.91 -1,069
2026-04-14 MYGN / Myriad Genetics, Inc. 4 Muzzey Dale F - Taxes D 4.91 -946
2026-04-13 QCLS / Q/C Technologies, Inc. 4 Silverman Joshua A - Award D 162,162
2026-03-26 IMDX / Insight Molecular Diagnostics Inc. 4 Liu James Yang M - Exercise D 6,289
2026-03-26 IMDX / Insight Molecular Diagnostics Inc. 4 Riggs Josh M - Exercise D 47,170
2026-03-26 IMDX / Insight Molecular Diagnostics Inc. 4 James Andrea S. M - Exercise D 28,302
2026-03-26 IMDX / Insight Molecular Diagnostics Inc. 4 James Andrea S. F - Taxes D 4.11 -11,298
2026-03-26 IMDX / Insight Molecular Diagnostics Inc. 4 Liu James Yang F - Taxes D 4.11 -2,578
2026-03-26 IMDX / Insight Molecular Diagnostics Inc. 4 Riggs Josh F - Taxes D 4.11 -12,310
2026-03-22 MYGN / Myriad Genetics, Inc. 4 Verratti Mark F - Taxes D 4.58 -2,055
2026-03-22 MYGN / Myriad Genetics, Inc. 4 Muzzey Dale F - Taxes D 4.58 -2,019
2026-03-22 MYGN / Myriad Genetics, Inc. 4 Wheeler Benjamin Richard F - Taxes D 4.58 -549
2026-03-20 ICCC / ImmuCell Corporation 4 BRIGHAM MICHAEL F M - Exercise D 5.84 25,000
2026-03-20 ICCC / ImmuCell Corporation 4 BRIGHAM MICHAEL F F - Taxes D 6.07 -24,052
2026-03-17 VNRX / VolitionRx Limited 4 Micallef Jacob Vincent F - Taxes D 0.19 -5,310
2026-03-17 VNRX / VolitionRx Limited 4 Rootsaert Rodney Gerard F - Taxes D 0.19 -3,948
2026-03-17 VNRX / VolitionRx Limited 4 Forterre Gael F - Taxes D 0.19 -5,251
2026-03-17 VNRX / VolitionRx Limited 4 Plummer Nicholas F - Taxes D 0.19 -7,003
2026-03-15 MYGN / Myriad Genetics, Inc. 4 Verratti Mark F - Taxes D 4.66 -5,611
2026-03-15 MYGN / Myriad Genetics, Inc. 4 Verratti Mark F - Taxes D 4.66 -9,096
2026-03-15 MYGN / Myriad Genetics, Inc. 4 Wheeler Benjamin Richard F - Taxes D 4.66 -2,192
2026-03-15 MYGN / Myriad Genetics, Inc. 4 Wheeler Benjamin Richard F - Taxes D 4.66 -877
2026-03-15 MYGN / Myriad Genetics, Inc. 4 Muzzey Dale F - Taxes D 4.66 -4,783
2026-03-15 MYGN / Myriad Genetics, Inc. 4 Haas Kevin Richard F - Taxes D 4.66 -3,355
2026-03-15 MYGN / Myriad Genetics, Inc. 4 Haas Kevin Richard F - Taxes D 4.66 -8,382
2026-03-15 MYGN / Myriad Genetics, Inc. 4 Muzzey Dale F - Taxes D 4.66 -11,949
2026-03-14 MYGN / Myriad Genetics, Inc. 4 Haas Kevin Richard F - Taxes D 4.66 -4,161
2026-03-14 MYGN / Myriad Genetics, Inc. 4 Muzzey Dale F - Taxes D 4.66 -8,288
2026-03-14 MYGN / Myriad Genetics, Inc. 4 Solaiman Shereen F - Taxes D 4.66 -5,784
2026-03-14 MYGN / Myriad Genetics, Inc. 4 Raha Samraat S. F - Taxes D 4.66 -10,816
2026-03-14 MYGN / Myriad Genetics, Inc. 4 Verratti Mark F - Taxes D 4.66 -5,418
2026-03-14 MYGN / Myriad Genetics, Inc. 4 Wheeler Benjamin Richard F - Taxes D 4.66 -1,097
2026-03-13 MYGN / Myriad Genetics, Inc. 4 Fox Jennifer Lynne F - Taxes D 4.66 -5,995
2026-03-13 MYGN / Myriad Genetics, Inc. 4 Wheeler Benjamin Richard F - Taxes D 4.66 -586
2026-03-13 MYGN / Myriad Genetics, Inc. 4 Haas Kevin Richard F - Taxes D 4.66 -6,412
2026-03-13 MYGN / Myriad Genetics, Inc. 4 Solaiman Shereen F - Taxes D 4.66 -8,899
2026-03-13 MYGN / Myriad Genetics, Inc. 4 Muzzey Dale F - Taxes D 4.66 -12,779
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)